Dendracin Neurodendraxcin Lotion
NDC Package 68788-7696-6
Package Information
Dendracin Neurodendraxcin (methyl salicylate, menthol and capsaicin) lotions is use only as directed. This formulation utilizes a lotion delivery system. Marketed by Preferred Pharmaceuticals, Inc., this product is identified by NDC 68788-7696 and is authorized under FDA application MO17.
Identification & Billing
- RxCUI: 1116967 - capsaicin 0.025 % / menthol 10 % / methyl salicylate 30 % Topical Lotion
- RxCUI: 1116967 - capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion
- RxCUI: 1116971 - DENDRACIN Neurodendraxcin 0.025 % / 10 % / 30 % Topical Lotion
- RxCUI: 1116971 - capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Lotion [Dendracin Neurodendraxcin]
- RxCUI: 1116971 - Dendracin Neurodendraxcin (capsaicin 0.025 % / menthol 10 % / methyl salicylate 30 % ) Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68788 - Preferred Pharmaceuticals, Inc.
- 68788-7696 - Dendracin Neurodendraxcin
- 68788-7696-6 - 60 mL in 1 BOTTLE
- 68788-7696 - Dendracin Neurodendraxcin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68788-7696). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68788-7696-6 identifies a specific commercial package of 60 ml in 1 bottle of Dendracin Neurodendraxcin, a human over the counter drug labeled by Preferred Pharmaceuticals, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 60 billable units per package. This lotion is formulated for topical use and contains capsaicin; menthol, unspecified form; methyl salicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Preferred Pharmaceuticals, Inc. on April 01, 2020. The current certification is valid through December 31, 2027.
How is this Preferred Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68788769606. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.